Westfield Capital Management’s Cidara Therapeutics CDTX Stock Holding History

Westfield Capital Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,411	Closed	-$312K	–	261
2025 Q4	$312K	Buy	+1,411	New	+$228K	﹤0.01%	237

Westfield Capital Management's CDTX Position: Q1 2026 in Review

Westfield Capital Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 1,411 shares — an estimated $312K sold.

Westfield Capital Management first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $312K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Westfield Capital Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Westfield Capital Management sold 1,411 Cidara Therapeutics shares in Q1 2026, an estimated $312K.
Westfield Capital Management first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Westfield Capital Management's Cidara Therapeutics position peaked at $312K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Westfield Capital Management's 13F filing for Q1 2026, filed 11 May 2026.